CONMED Total Current Liabilities 2010-2024 | CNMD

CONMED total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
CONMED Annual Total Current Liabilities
(Millions of US $)
2023 $311
2022 $297
2021 $197
2020 $190
2019 $188
2018 $161
2017 $150
2016 $114
2015 $120
2014 $116
2013 $111
2012 $125
2011 $131
2010 $180
2009 $79
CONMED Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $282
2024-06-30 $266
2024-03-31 $291
2023-12-31 $311
2023-09-30 $376
2023-06-30 $353
2023-03-31 $321
2022-12-31 $297
2022-09-30 $209
2022-06-30 $201
2022-03-31 $188
2021-12-31 $197
2021-09-30 $183
2021-06-30 $198
2021-03-31 $182
2020-12-31 $190
2020-09-30 $179
2020-06-30 $151
2020-03-31 $160
2019-12-31 $188
2019-09-30 $161
2019-06-30 $156
2019-03-31 $151
2018-12-31 $161
2018-09-30 $165
2018-06-30 $177
2018-03-31 $159
2017-12-31 $150
2017-09-30 $139
2017-06-30 $130
2017-03-31 $125
2016-12-31 $114
2016-09-30 $113
2016-06-30 $106
2016-03-31 $103
2015-12-31 $120
2015-09-30 $112
2015-06-30 $110
2015-03-31 $113
2014-12-31 $116
2014-09-30 $122
2014-06-30 $105
2014-03-31 $101
2013-12-31 $111
2013-09-30 $101
2013-06-30 $99
2013-03-31 $97
2012-12-31 $125
2012-09-30 $126
2012-06-30 $135
2012-03-31 $166
2011-12-31 $131
2011-09-30 $233
2011-06-30 $210
2011-03-31 $181
2010-12-31 $180
2010-09-30 $117
2010-06-30 $107
2010-03-31 $106
2009-12-31 $79
2009-09-30 $81
2009-06-30 $64
2009-03-31 $65
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.215B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49